Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,090 DKK | -0.91% | +4.11% | -18.05% |
Mar. 27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-18.05% | 5.58M | |
-2.82% | 103B | |
+0.68% | 95.71B | |
+1.37% | 22.02B | |
-17.42% | 20.9B | |
-9.28% | 17.85B | |
-42.83% | 16.21B | |
-15.67% | 15.52B | |
+4.81% | 13.86B | |
+32.45% | 12.04B |
- Stock Market
- Equities
- ORPHA Stock
- News Orphazyme A/S
- Orphazyme A/S : BofA Securities Lowers Orphazyme A/S to Underperform From Neutral, Price Target to $5 From $13